Completed

Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment: A Randomized Controlled Trial

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Hydrocolloid dressing

+ Petrolatum jelly dressing

DeviceOther
Who is being recruted

Surgical Wound+13

+ Treatment Adherence and Compliance

+ Behavior

Over 18 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: October 2022
See protocol details

Summary

Principal SponsorIndiana University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 17, 2022

Actual date on which the first participant was enrolled.

Patients will be randomized either to receive standard daily dressing or hydrocolloid dressing using a randomization generator. After closing the wound with the sutures,the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days(Experimental) or the standard dressing (Control) that will be covered with petrolatum jelly and bandaging during this time period, which has to be re-applied daily. Patients and dermatologic surgeons will then complete surveys 7 days, 30 days, and 90 days after surgery to evaluate the cosmetic appearance of these scars.

Official TitleScar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment: A Randomized Controlled Trial
NCT05618912
Principal SponsorIndiana University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

146 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Surgical WoundTreatment Adherence and ComplianceBehaviorCicatrixFibrosisNeoplasmsNeoplasms by SitePathologic ProcessesSkin DiseasesSkin NeoplasmsPathological Conditions, Signs and SymptomsWounds and InjuriesHealth BehaviorPatient SatisfactionSkin and Connective Tissue DiseasesPatient Preference

Criteria

3 inclusion criteria required to participate
Adult > 18 years of age
Linear scars
Patients underwent conventional excision or Mohs micrographic surgery for primary cutaneous cancer or other cutaneous condition that required surgical intervention
6 exclusion criteria prevent from participating
Scar localization on acral or hair bearing sites
Patients unable to converse in English
Patients requiring flap or graft for closure of wound
History of allergy to adhesives
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)

Group II

Active Comparator
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

IU Health Physicians Dermatology Meridian Crossing

Carmel, United StatesOpen IU Health Physicians Dermatology Meridian Crossing in Google Maps
CompletedOne Study Center